LLNI Funded Publications
Foetal liver suspensions in the treatment of marrow aplasia
Author:Bridges J B
Other Authors: Bridges J M, Edelstyn G J A, Lyons A R,
Journal:Brit. J. Cancer
Date: 1965
Further evidence that antigen selection shapes the Ig repertoire in CLL.
Author:Alexander HD
Other Authors:
Journal:Leuk Res
Date: March 2008
G-CSF increases proteasome activity in myeloid cells
Author:SM Mc Closkey
Other Authors: P Windrum, MF Mc Mullin, B Walker, AE Irvine,
Journal:Br J Haematol
Date: 2008
GATA2 regulates the erythropoietin receptor in t(12;21) ALL.
Author:Gaine ME
Other Authors: Sharpe DJ, Smith JS, Colyer HAA, Hodges VM, Lappin TR, Mills KI,
Last Updated:22/10/2019
Source:PubMed
Original Source:PubMed
Type:Journal Article
DOI:10.18632/oncotarget.19792
Journal:Oncotarget
Volume:8
Issue:39
Pages:66061-66074
Date: September 2017
Gene expression profiling for the diagnosis and prognosis of acute myeloid leukaemia. Frontiers in Biosciences
Author:KI Mills
Other Authors:
Journal:Frontiers in Biosciences
Date: 2008
Gene expression profiling in MDS and AML: potential and future avenues
Author:Theilgaard-Monch K
Other Authors: Boultwood J, Ferrari S, Giannopoulos K, Hernandez-Rivas J M, Kohlmann A, Morgan M, Porse B, Tagliafico E, Zwaan C M, Wainscoat J, Van den Heuvel-Eibrink MM, Mills K, Bullinger L,
Journal:Leukemia
Date: 2011
Genetic origins and clinical phenotype of familial and acquired erythrocytosis and thrombocytosis
Author:Percy MJ
Other Authors: Rumi E,
Journal:Am J Hematol
Date: January 2009
Genetic variation at the 8q24 locus confers risk to multiple myeloma
Author:Tewari P
Other Authors: Ryan A W, Hayden P J, Catherwood M, Drain S, Staines A, Grant T, Nieters A, Becker N, de S S, Foretova L, Maynardie M, Cocco P, Boffetta P, Brennan P, Chanock S, Lawler M, Browne P V,
Journal:Br J Haematol
Date: 2011
Link:https://onlinelibrary.wiley.com/doi/full/10.1111/j.1365-2141.2011.08798.x
Genomics in Hemato-Oncology: The paradigm of acute myeloid leukaemia
Author:KI Mills
Other Authors:
Journal:Genomics in Clinical Medicine” Ed D Kumar
Date: 2008
GEP analysis validates high risk MDS and acute myeloid leukemia post MDS mice models and highlights novel dysregulated pathways.
Author:Guerenne L
Other Authors: Beurlet S, Said M, Gorombei P, Le Pogam C, Guidez F, de la Grange P, Omidvar N, Vanneaux V, Mills K, Mufti GJ, Sarda-Mantel L, Noguera ME, Pla M, Fenaux P, Padua RA, Chomienne C, Krief P,
Last Updated:22/10/2019
Source:PubMed
Original Source:ORCID
Type:Journal Article
DOI:10.1186/s13045-016-0235-8
Journal:Journal of hematology & oncology
Volume:9
Pages:5
Date: January 2016
Link:https://pureadmin.qub.ac.uk/ws/portalfiles/portal/18189185/GEP_analysis_validates_high_risk_MDS.pdf
Global methylation and expression changes in acute myeloid leukemia cell lines reveal clustering patterns after treatment with a demethylating agent
Author:HAA Colyer
Other Authors: M Dellett, K O’Hagan, KI Mills,
Journal:Brit. J. Haem
Date: 2010
Global methylation changes in acute myeloid leukaemia cell lines after treatment with a demethylating agent identifies candidate genes for investigation into restored expression
Author:H Colyer
Other Authors: M Dellett, KI Mills,
Journal:Brit.J.Haem
Date: 2009